{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:41:33Z","timestamp":1775155293450,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Translational Cancer Research Network. No grant number as this is a PhD stipend"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic counselling and testing have utility for people with palliative care needs and their families. However, genetic and palliative care health professionals have described difficulties initiating palliative-genetic discussions. Between March and July 2022, we received <jats:italic>n<\/jats:italic>\u2009=\u200973 surveys (6% response rate) from genetic and palliative care health professionals in Australia and New Zealand that assessed and compared barriers and facilitators. The main perceived barrier to both groups was palliative care health professionals\u2019 lack of genetic knowledge (44%). Most palliative care health professionals were \u2018not at all confident\u2019 performing several activities, including discussing DNA banking (52%) and knowing their legal responsibilities when sharing genetic information (58%). The most frequently selected facilitator for genetic health professionals was fostering close relationships with palliative care health professionals (52%), while palliative care health professionals indicated a genetic referral template (51%) would be of assistance. Almost all participants agreed genetic discussions do not undermine the central ethos of palliative care (87%). Fewer palliative care health professionals considered themselves well situated to have genetic discussions with a palliative patient\u2019s family compared to genetic health professionals (<jats:italic>p<\/jats:italic>\u2009=\u20090.014). Our results suggest that genetic and palliative care health professionals support integrating genetics into palliative care, although refinement of the palliative care health professionals\u2019 role in this process is required. We have identified intervention targets to overcome barriers related to knowledge and confidence, which ought to be integrated into future interventions designed to support health professionals deliver the benefits of genetic information to people with palliative care needs and their families.<\/jats:p>","DOI":"10.1038\/s41431-023-01409-6","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T06:07:18Z","timestamp":1687327638000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A survey of genetic and palliative care health professionals\u2019 views of integrating genetics into palliative care"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-6397","authenticated-orcid":false,"given":"Stephanie","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6650-9702","authenticated-orcid":false,"given":"Erin","family":"Turbitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-6576","authenticated-orcid":false,"given":"Kathy","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-1190","authenticated-orcid":false,"given":"Alison","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-8872","authenticated-orcid":false,"given":"Megan","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9557-9080","authenticated-orcid":false,"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"1409_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2019.00040","volume":"7","author":"GA Bilkey","year":"2019","unstructured":"Bilkey GA, Burns BL, Coles EP, Bowman FL, Beilby JP, Pachter NS, et al. Genomic testing for human health and disease across the life cycle: applications and ethical, legal, and social challenges. Front Public Health. 2019;7:1\u201311.","journal-title":"Front Public Health"},{"key":"1409_CR2","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA."},{"key":"1409_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/jpm.2021.0169","volume":"25","author":"AL Buras","year":"2022","unstructured":"Buras AL, Barkhurst M, Rutherford TJ, Anderson ML, English DP. The intersection of palliative care and genetic counseling in cancer care: a case discussion. J Palliat Med. 2022;25:167\u201371.","journal-title":"J Palliat Med"},{"key":"1409_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12687-017-0345-1","volume":"9","author":"A Dearing","year":"2018","unstructured":"Dearing A, Taverner N. Mainstreaming genetics in palliative care: barriers and suggestions for clinical genetic services. J Community Genet. 2018;9:243\u201356.","journal-title":"J Community Genet"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1001\/jamaoncol.2019.0846","volume":"5","author":"J Solimine","year":"2019","unstructured":"Solimine J. Genetic testing after a terminal diagnosis-providing purpose. JAMA Oncol. 2019;5:936\u20137.","journal-title":"JAMA Oncol"},{"key":"1409_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s10897-017-0181-9","volume":"27","author":"JM Quillin","year":"2018","unstructured":"Quillin JM, Emidio O, Ma B, Bailey L, Smith TJ, Kang IG, et al. High-risk palliative care patients\u2019 knowledge and attitudes about hereditary cancer testing and DNA banking. J Genet. Couns. 2018;27:834\u201343.","journal-title":"J Genet. Couns"},{"key":"1409_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41436-020-0785-6","volume":"22","author":"S White","year":"2020","unstructured":"White S, Jacobs C, Phillips J. Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care. Genet Med. 2020;22:1149\u201355.","journal-title":"Genet Med"},{"key":"1409_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10689-016-9893-5","volume":"15","author":"H Hampel","year":"2016","unstructured":"Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer. 2016;15:423\u20137.","journal-title":"Fam Cancer"},{"key":"1409_CR9","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41436-020-0825-2","volume":"22","author":"N Dragojlovic","year":"2020","unstructured":"Dragojlovic N, Borle K, Kopac N, Ellis U, Birch P, Adam S, et al. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet Med. 2020;22:1437\u201349.","journal-title":"Genet Med"},{"key":"1409_CR10","doi-asserted-by":"publisher","first-page":"e13480","DOI":"10.1111\/ecc.13480","volume":"30","author":"C Jacobs","year":"2021","unstructured":"Jacobs C, Rahman B. One size does not fit all: The case for targeted education in genetics and genomics for cancer nurses. Eur J Cancer Care (Engl). 2021;30:e13480.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1409_CR11","doi-asserted-by":"publisher","first-page":"e044408","DOI":"10.1136\/bmjopen-2020-044408","volume":"11","author":"A Nisselle","year":"2021","unstructured":"Nisselle A, King EA, McClaren B, Janinski M, Metcalfe S, Gaff C. Measuring physician practice, preparedness and preferences for genomic medicine: a national survey. BMJ Open. 2021;11:e044408.","journal-title":"BMJ Open"},{"key":"1409_CR12","first-page":"1","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:1\u201311.","journal-title":"BMJ."},{"key":"1409_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00520-017-4017-9","volume":"26","author":"A Morrow","year":"2018","unstructured":"Morrow A, Jacobs C, Best M, Greening S, Tucker K. Genetics in palliative oncology: a missing agenda? A review of the literature and future directions. Support Care Cancer. 2018;26:721\u201330.","journal-title":"Support Care Cancer"},{"key":"1409_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10689-017-0021-y","volume":"17","author":"C Gonthier","year":"2018","unstructured":"Gonthier C, Pelletier S, Gagnon P, Marin A, Chiquette J, Gagnon B, et al. Issues related to family history of cancer at the end of life: a palliative care providers\u2019 survey. Fam Cancer. 2018;17:303\u20137.","journal-title":"Fam Cancer"},{"key":"1409_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1200\/JOP.2010.000190","volume":"7","author":"JM Quillin","year":"2011","unstructured":"Quillin JM, Bodurtha JN, Siminoff LA, Smith TJ. Physicians\u2019 current practices and opportunities for DNA banking of dying patients with cancer. J Oncol Pract. 2011;7:183\u20137.","journal-title":"J Oncol Pract"},{"key":"1409_CR16","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00520-021-06569-z","volume":"30","author":"S White","year":"2022","unstructured":"White S, Phillips J, Turbitt E, Jacobs C. Views and experiences of palliative care clinicians in addressing genetics with individuals and families: a qualitative study. Support Care Cancer. 2022;30:1615\u201324.","journal-title":"Support Care Cancer"},{"key":"1409_CR17","doi-asserted-by":"publisher","unstructured":"White S, Turbitt E, Phillips J, Jacobs C. Approaching discussions about genetics with palliative patients, and their families: a qualitative exploration with genetic health professionals. Eur J Hum Genet [Internet]. 2022:1\u20138. https:\/\/doi.org\/10.1038\/s41431-022-01179-7.","DOI":"10.1038\/s41431-022-01179-7"},{"key":"1409_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41416-018-0271-y","volume":"119","author":"M Friedlander","year":"2018","unstructured":"Friedlander M, Matulonis U, Gourley C, du Bois A, Vergote I, Rustin G, et al. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. Br J Cancer. 2018;119:1075\u201385.","journal-title":"Br J Cancer"},{"key":"1409_CR19","unstructured":"Ingleby L. Clinical genetics in a palliative care setting: a qualitative exploration of the barriers and levers staff report when discussing family risk of BRCA 1 and BRCA 2 mutations [dissertation on the Internet]. Leicester (UK): University of Leicester; 2015. [cited 12 August 2019]. Available from: https:\/\/leicester.figshare.com\/articles\/thesis\/Clinical_Genetics_in_a_Palliative_Care_Setting_A_Qualitative_Exploration_of_the_Barriers_and_Levers_Staff_Report_when_Discussing_Family_Risk_of_BRCA_1_and_BRCA_2_mutations\/10168916\/1\/files\/18326246.pdf."},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0269216310383738","volume":"25","author":"AK Lillie","year":"2010","unstructured":"Lillie AK, Clifford C, Metcalfe A. Caring for families with a family history of cancer: why concerns about genetic predisposition are missing from the palliative agenda. Palliat Med. 2010;25:117\u201324.","journal-title":"Palliat Med"},{"key":"1409_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-2702.2009.02935.x","volume":"19","author":"A Metcalfe","year":"2010","unstructured":"Metcalfe A, Pumphrey R, Clifford C. Hospice nurses and genetics: implications for end-of-life care. J Clin Nurs. 2010;19:192\u2013207.","journal-title":"J Clin Nurs"},{"key":"1409_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/0269216319845826","volume":"33","author":"JE Cleophat","year":"2019","unstructured":"Cleophat JE, Pelletier S, Joly Y, Gagnon P, D\u00e9ry A, Marin A, et al. Addressing cancer family history at the end of life: how frequent, relevant, and feasible is it? A survey of palliative care providers. Palliat Med. 2019;33:856\u20138.","journal-title":"Palliat Med"},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1177\/1049909118778865","volume":"35","author":"MS Abusamaan","year":"2018","unstructured":"Abusamaan MS, Quillin JM, Owodunni O, Emidio O, Kang IG, Yu B, et al. The role of palliative medicine in assessing hereditary cancer risk. Am J Hosp Palliat Care. 2018;35:1490\u20137.","journal-title":"Am J Hosp Palliat Care"},{"key":"1409_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","volume":"18","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800\u20134.","journal-title":"Epidemiology"},{"key":"1409_CR25","unstructured":"American Psychological Association. APA PsycTests\u00ae [Internet]. 2022 [cited 2022 1 March]. Available from: https:\/\/www.apa.org\/pubs\/databases\/psyctests."},{"key":"1409_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:1\u201324.","journal-title":"J Biomed Inf"},{"key":"1409_CR27","unstructured":"World Health Organization. Innovative care for chronic conditions: building blocks for action (Global report). Geneva, Switzerland: Noncommunicable Diseases and Mental Health, World Health Organization; 2002."},{"key":"1409_CR28","unstructured":"Victorian Government. Data collection standards\u2014culturally and linguistically diverse communities. 2021 [cited 2022 22 January]. Available from: https:\/\/www.vic.gov.au\/victorian-family-violence-data-collection-framework\/data-collection-standards-culturally-and."},{"key":"1409_CR29","unstructured":"IBM Corp. IBM SPSS Statistics for Windows, Version 28.0. [Software]. Armonk, NY: IBM Corp2021 [cited 2022 28 June]."},{"key":"1409_CR30","unstructured":"R Core Team. R: a language and environment for statistical computing [Software]. Vienna, Austria: R Foundation for Statistical Computing; 2022 [cited 2022 15 September]. Available from: https:\/\/www.R-project.org\/."},{"key":"1409_CR31","unstructured":"Wickham H ggplot2: elegant Graphics for Data Analysis [Software]. New York: Springer-Verlag; 2016 [cited 2022 2 September]."},{"key":"1409_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2190\/OM.56.1.c","volume":"56","author":"D Kissane","year":"2008","unstructured":"Kissane D, Lichtenthal WG, Zaider T. Family care before and after bereavement. Omega (Westport). 2008;56:21\u201332.","journal-title":"Omega (Westport)"},{"key":"1409_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ygyno.2020.05.001","volume":"158","author":"M Gleeson","year":"2020","unstructured":"Gleeson M, Kentwell M, Meiser B, Do J, Nevin S, Taylor N, et al. The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients. Gynecol Oncol. 2020;158:431\u20139.","journal-title":"Gynecol Oncol"},{"key":"1409_CR34","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1089\/jpm.2012.0583","volume":"16","author":"NS Lakhani","year":"2013","unstructured":"Lakhani NS, Weir J, Allford A, Kai J, Barwell JG. Could triaging family history of cancer during palliative care enable earlier genetic counseling intervention? J Palliat Med. 2013;16:1350\u20135.","journal-title":"J Palliat Med"},{"key":"1409_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12687-020-00491-3","volume":"12","author":"L Bradley","year":"2021","unstructured":"Bradley L, Lynch SA. Dying to see you? Deaths on a clinical genetics waiting list in the Republic of Ireland; what are the consequences? J Community Genet. 2021;12:121\u20137.","journal-title":"J Community Genet"},{"key":"1409_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41431-021-01036-z","volume":"30","author":"A Crook","year":"2022","unstructured":"Crook A, McEwen A. Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS\/MND: diagnostic testing comes first. Eur J Hum Genet. 2022;30:394\u20135.","journal-title":"Eur J Hum Genet"},{"key":"1409_CR37","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.18632\/oncotarget.28076","volume":"12","author":"S Thavaneswaran","year":"2021","unstructured":"Thavaneswaran S, Ballinger M, Butow P, Meiser B, Goldstein D, Lin F, et al. The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey. Oncotarget. 2021;12:2169\u201376.","journal-title":"Oncotarget"},{"key":"1409_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-4394-5","volume":"19","author":"KM Kokorelias","year":"2019","unstructured":"Kokorelias KM, Gignac MAM, Naglie G, Cameron JI. Towards a universal model of family centered care: a scoping review. BMC Health Serv Res. 2019;19:1\u201311.","journal-title":"BMC Health Serv Res"},{"key":"1409_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5920-x","volume":"19","author":"MC Best","year":"2019","unstructured":"Best MC, Bartley N, Jacobs C, Juraskova I, Goldstein D, Newson AJ, et al. Patient perspectives on molecular tumor profiling: \u201cWhy wouldn\u2019t you?\u201d. BMC Cancer. 2019;19:753.","journal-title":"BMC Cancer"},{"key":"1409_CR40","unstructured":"Australian Health Ministers\u2019 Advisory Council. National health genomics policy framework 2018-2021 [Internet]. 2017 [cited 2022 14 June]. Available from: https:\/\/www.health.gov.au\/resources\/collections\/national-health-genomics-policy-framework."},{"key":"1409_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ygyno.2017.01.030","volume":"145","author":"M Kentwell","year":"2017","unstructured":"Kentwell M, Dow E, Antill Y, Wrede CD, McNally O, Higgs E, et al. Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecol Oncol. 2017;145:130\u20136.","journal-title":"Gynecol Oncol"},{"key":"1409_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ygyno.2017.07.141","volume":"147","author":"L Senter","year":"2017","unstructured":"Senter L, O\u2019Malley DM, Backes FJ, Copeland LJ, Fowler JM, Salani R, et al. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care. Gynecol Oncol. 2017;147:110\u201314.","journal-title":"Gynecol Oncol"},{"key":"1409_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10897-012-9567-x","volume":"22","author":"A McEwen","year":"2013","unstructured":"McEwen A, Young M, Wake S. Genetic counseling training and certification in Australasia. J Genet Couns. 2013;22:875\u201384.","journal-title":"J Genet Couns"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01409-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:04:07Z","timestamp":1704672247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01409-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1038\/s41431-023-01409-6","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the University of Technology Sydney Human Research Ethics Committee (ETH19-2408\/21-5854) All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Implied informed consent was obtained for individuals who voluntarily completed the online survey and submitted their responses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}